Endocrinology

Top Story

Lifestyle intervention improves health-related quality of life in prediabetes, metabolic syndrome

July 28, 2016

Adults with prediabetes or metabolic syndrome assigned to an intensive 12-month lifestyle intervention program saw improvements in health-related quality of life, as well as improved clinical and behavioral outcomes vs. controls assigned to a waiting list, according to recent findings.

“These community-based lifestyle intervention programs have additional valuable benefits, beyond the improvement of risk factors for type 2 diabetes and heart disease,” Yvonne L. Eaglehouse, PhD, a postdoctoral researcher in the department of epidemiology at the University of Pittsburgh Graduate School of Public Health, said in a press release. “Our study demonstrates that these programs, delivered in diverse community settings, such as senior centers and work sites, simultaneously and significantly improved the quality of life of the participants.”

In the Journals Plus

Portion-size preference does not determine BMI

July 28, 2016
Adults with overweight do not choose larger food portions than their normal-weight peers, according to recent findings. “Large portions of food are often blamed…
In the Journals Plus

Later-onset menarche, menopause associated with longevity

July 28, 2016
Women with later-onset menarche, later natural or surgical menopause and a longer reproductive lifespan are more likely to live to age 90 years vs. women with…
FDA News

FDA approves Adlyxin for type 2 diabetes

July 28, 2016
The FDA has approved the once-daily glucagon-like peptide-1 receptor agonist Adlyxin, a once-daily injection to improve glycemic control along with diet and exercise in…
In the Journals

Use of EHRs, CPOE associated with physician burnout, dissatisfaction

July 27, 2016
Physicians reported low satisfaction with their electronic health records and computerized physician order entry, according to findings published in Mayo Clinic
More News Headlines »
CME

Obesity Consults® ObesityForum® 2015 Highlights

This activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc. and Novo Nordisk, Inc.

Obesity has increased dramatically in the past 20 years and is considered a health care epidemic in the United States…
More »
Video

VIDEO: Combination therapy is ‘the wave of the future’ for diabetes treatment

June 30, 2016
More »
Featured
Highlights from AACE

Highlights from AACE

CME

New Treatment Paradigms for Diabetic Retinopathy: Current Status and Applications for Practice

This activity is supported by an educational grant from Genentech, Inc.

Despite a number of effective treatment options, diabetic eye disease is a leading cause of vision loss in the United…
More »
Current Issues
View the Current Issues